Indapta Therapeutics Funding: $73M Raised, Series A (2024)
Indapta Therapeutics is based in San Francisco. It has raised $73M in total funding. Latest round: Series A.
Indapta Therapeutics funding overview
Indapta Therapeutics is based in San Francisco. Indapta Therapeutics has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Indapta Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include RA Capital Management, LP, Vertex Ventures HC, Leaps By Bayer, Myeloma Investment Fund, Lonza, Pontifax. 6 distinct backers are named across the disclosed rounds.
Indapta Therapeutics at a glance
Total raised
$73M
Latest round
Series A
Latest round date
December 2024
Headquarters
San Francisco
Notable investors
RA Capital Management, LP, Vertex Ventures HC, Leaps By Bayer, Myeloma Investment Fund, Lonza, Pontifax
Frequently asked about Indapta Therapeutics funding
How much has Indapta Therapeutics raised?
Indapta Therapeutics has raised $73M in total disclosed funding across the rounds on record.
Who has invested in Indapta Therapeutics?
RA Capital Management, LP, Vertex Ventures HC, Leaps By Bayer, Myeloma Investment Fund, Lonza, Pontifax are named among the investors backing Indapta Therapeutics.
What was the latest Indapta Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2024.
Where is Indapta Therapeutics based?
Indapta Therapeutics is based in San Francisco.
When did Indapta Therapeutics last raise?
The last disclosed Indapta Therapeutics round closed in December 2024 at Series A.
Every Indapta Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.
